Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification
- 29 June 2010
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 49 (10), 901-909
- https://doi.org/10.1002/gcc.20798
Abstract
Treatment success of breast cancer patients with trastuzumab alone or in combination depends not only on HER2/NEU amplification but also on PTEN and PI3K status and efficient cell death programs. In this pilot study, we found a significant association between loss of beclin 1 and HER2/NEU amplification (both on 17q21) in breast cancers. This finding was confirmed in two public copy number microarray datasets. Furthermore, there is a trend associating beclin 1 loss with TP53 mutations, PI3KCA gene gain, and PTEN mutations. Finally, the observation that beclin 1 gene loss predicted a response to trastuzumab alone or in combination with other drugs is worthy of further confirmation in larger cohorts. Our results suggest that, beclin 1 loss may contribute to genome instability and to a defective autophagy that may lead to tumoral cell death in presence of competent apoptosis or senescence pathways.This publication has 29 references indexed in Scilit:
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked casesLaboratory Investigation, 2008
- High-resolution genomic and expression analyses of copy number alterations in breast tumorsGenes, Chromosomes and Cancer, 2008
- A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast CancerCancer Cell, 2007
- GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductorBioinformatics, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Bioconductor: open software development for computational biology and bioinformaticsGenome Biology, 2004
- Reversal of human cellular senescence: roles of the p53 and p16 pathwaysThe EMBO Journal, 2003
- Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath TumorsLaboratory Investigation, 2001
- Cloning and Genomic Organization of Beclin 1, a Candidate Tumor Suppressor Gene on Chromosome 17q21Genomics, 1999